QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
OTCMKTS:BVNRY

Bavarian Nordic A/S - BVNRY Stock Forecast, Price & News

$8.82
+0.25 (+2.92%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$8.72
$8.82
50-Day Range
$8.46
$12.25
52-Week Range
$5.85
$19.31
Volume
3,684 shs
Average Volume
15,281 shs
Market Capitalization
$1.87 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BVNRY stock logo

About Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock

Bavarian Nordic A/S is a fully-integrated biotechnology company focused on vaccination technology. The company’s work is built around two primary platforms that provide numerous benefits to the health industry and individuals. The company’s primary technology is MVA-BN which stands for Modified Vaccine Ankara-Bavarian Nordic. This vaccination platform is a non-replicating platform, meaning that live-virus vaccines cannot reproduce and spread within the host. This is central to the platform's high tolerance rate. MVA-BN is approved as a smallpox and monkeypox vaccine in the US, Canada, and the EU. It is also included in the US Strategic National Stockpile and is being used worldwide to control the 2022 Monkeypox outbreak.

Bavarian Nordic is headquartered in Hellerup, Denmark with manufacturing sites in Denmark and Germany. The company maintains offices in Switzerland, the UK, Japan, and North Carolina in the United States. The company was incorporated in 1992 and had 4 approved products under 7 brand names available for use. Its MVA-BN non-replicating smallpox and monkeypox vaccines are available under the IMVAMUNE, IMVANEX and JYNNEOS names.

The company’s second platform is the Vaccinia-Fowlpox-TRICOM platform for treating cancers. The platform can be targeted to attack specific markers found in numerous cancers. The company’s other marketable vaccines are Rabipur for rabies, MVABEA for Ebola and Marburg Hemorrhagic fever, and Encepur for tick-borne encephalitis.

The company’s pipeline has 4 potential candidates for the market. These include a freeze-dried version of MVA-BN for smallpox, MVA-BN for RSV (respiratory infection), and TAEK-VAC for certain cancers. The company’s COVID-19/SARS vaccine boosters have shown effectiveness 6 months after dosing. 

Receive BVNRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bavarian Nordic A/S and its competitors with MarketBeat's FREE daily newsletter.

BVNRY Stock News Headlines

Bavarian Nordic A/S reports FY results
How This Trader Banked A 97% Win Rate
Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. pixel
Bavarian Nordic Publishes Annual Report 2022
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
Bavarian Nordic rises on new U.S. Defense Department order
See More Headlines
Receive BVNRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bavarian Nordic A/S and its competitors with MarketBeat's FREE daily newsletter.

BVNRY Company Calendar

Today
3/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BVNRY
CIK
N/A
Employees
759
Year Founded
1994

Profitability

Net Income
$-73,950,000.00
Pretax Margin
-25.15%

Debt

Sales & Book Value

Annual Sales
$301.90 million
Book Value
$5.55 per share

Miscellaneous

Free Float
N/A
Market Cap
$1.87 billion
Optionable
Not Optionable
Beta
1.57

Social Links


Key Executives

  • Paul Chaplin
    President & Chief Executive Officer
  • Russell Thirsk
    Chief Operating Officer & Executive Vice President
  • Henrik Neilsen Juuel
    Chief Financial Officer & Executive Vice President
  • Laurence de Moerlooze
    Chief Medical Officer & Executive Vice President
  • Jean-Christophe May
    Chief Commercial Officer & Executive VP













BVNRY Stock - Frequently Asked Questions

Should I buy or sell Bavarian Nordic A/S stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bavarian Nordic A/S in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BVNRY shares.
View BVNRY analyst ratings
or view top-rated stocks.

How have BVNRY shares performed in 2023?

Bavarian Nordic A/S's stock was trading at $10.1501 at the beginning of the year. Since then, BVNRY shares have decreased by 13.1% and is now trading at $8.8240.
View the best growth stocks for 2023 here
.

What is Bavarian Nordic A/S's stock symbol?

Bavarian Nordic A/S trades on the OTCMKTS under the ticker symbol "BVNRY."

How do I buy shares of Bavarian Nordic A/S?

Shares of BVNRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bavarian Nordic A/S's stock price today?

One share of BVNRY stock can currently be purchased for approximately $8.82.

How much money does Bavarian Nordic A/S make?

Bavarian Nordic A/S (OTCMKTS:BVNRY) has a market capitalization of $1.87 billion and generates $301.90 million in revenue each year. The company earns $-73,950,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis.

How many employees does Bavarian Nordic A/S have?

The company employs 759 workers across the globe.

How can I contact Bavarian Nordic A/S?

Bavarian Nordic A/S's mailing address is Hejreskovvej 10A, Kvistgaard G7, 3490. The official website for the company is www.bavarian-nordic.com. The company can be reached via phone at (453) 326-8383, via email at investor@bavarian-nordic.com, or via fax at 45-3326-8380.

This page (OTCMKTS:BVNRY) was last updated on 3/21/2023 by MarketBeat.com Staff